Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$974M |
| 2 |
JD.com
JD
|
+$620M |
| 3 |
FIGS
FIGS
|
+$559M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$447M |
| 5 |
GE Aerospace
GE
|
+$417M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$989M |
| 2 |
Microsoft
MSFT
|
+$981M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
AbCellera Biologics
ABCL
|
+$648M |
| 5 |
O'Reilly Automotive
ORLY
|
+$541M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.71% |
| 2 | Technology | 23.68% |
| 3 | Financials | 11.86% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amazon
AMZN
$2.79T
| $1.63B | 4.95% |
9,484,340
+5,863,000
| +162% | +$974M |
|
2
BridgeBio Pharma
BBIO
$15.9B
| $1.62B | 4.92% |
26,620,991
| – | – |
|
3
Fidelity National Information Services
FIS
$21.3B
| $1.3B | 3.95% |
9,200,315
-398,159
| -4% | -$59.1M |
|
|
4
Microsoft
MSFT
$3.59T
| $1.26B | 3.82% |
4,655,350
-3,860,680
| -45% | -$981M |
|
|
5
GE Aerospace
GE
$361B
| $1.24B | 3.75% |
18,416,452
+6,247,992
| +51% | +$417M |
|
6
Adaptive Biotechnologies
ADPT
$4.15B
| $1.23B | 3.72% |
29,993,708
| – | – |
|
7
T-Mobile US
TMUS
$196B
| $1.09B | 3.31% |
7,542,189
-2,743,055
| -27% | -$378M |
|
8
Palo Alto Networks
PANW
$292B
| $980M | 2.97% |
15,842,358
+792,474
| +5% | +$47M |
|
|
COUP
9
DELISTED
Coupa Software Incorporated
COUP
| $944M | 2.86% |
3,599,829
+1,805,064
| +101% | +$447M |
|
10
Fortive
FTV
$18.1B
| $821M | 2.49% |
15,629,686
+780,369
| +5% | +$42.1M |
|
11
Centene
CNC
$32.1B
| $817M | 2.48% |
11,199,941
+222,890
| +2% | +$15.3M |
|
12
ServiceNow
NOW
$133B
| $815M | 2.47% |
7,411,935
+2,899,250
| +64% | +$294M |
|
13
Chubb
CB
$132B
| $782M | 2.37% |
4,920,334
+738,511
| +18% | +$122M |
|
14
Bristol-Myers Squibb
BMY
$137B
| $756M | 2.29% |
11,317,752
+6,122,279
| +118% | +$399M |
|
|
15
FIGS
FIGS
$2.44B
| $749M | 2.27% |
+14,942,689
| New | +$559M |
|
16
Corpay
CPAY
$27.4B
| $736M | 2.23% |
2,872,814
+240,491
| +9% | +$66.5M |
|
17
UnitedHealth
UNH
$350B
| $720M | 2.18% |
1,798,650
-1,282,224
| -42% | -$511M |
|
18
Meta Platforms (Facebook)
META
$1.4T
| $706M | 2.14% |
2,030,659
-317,979
| -14% | -$102M |
|
19
APi Group
APG
$17.8B
| $696M | 2.11% |
50,000,000
| – | – |
|
20
Aon
AON
$75.3B
| $693M | 2.1% |
2,903,054
+748,565
| +35% | +$183M |
|
|
21
JD.com
JD
$39.7B
| $658M | 1.99% |
+8,241,079
| New | +$620M |
|
22
Boston Scientific
BSX
$73B
| $569M | 1.73% |
13,315,816
-4,580,286
| -26% | -$193M |
|
23
Guardant Health
GH
$22.9B
| $529M | 1.6% |
4,256,363
+1,338,140
| +46% | +$180M |
|
24
Visa
V
$693B
| $519M | 1.57% |
2,219,163
-1,819,346
| -45% | -$416M |
|
25
Thermo Fisher Scientific
TMO
$233B
| $510M | 1.55% |
1,011,401
+149,514
| +17% | +$70.5M |
|
Similar funds
Andreas Halvorsen's Q2 2021 Portfolio in Review
As of Q2 2021, Andreas Halvorsen held 117 positions worth $33B, down 1.8% from $33.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Andreas Halvorsen withdrew a net $2.78B in Q2 2021, closing 29 positions and reducing 29 holdings. Its most notable exit was AbCellera Biologics, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 35% a quarter earlier, followed by Technology and Financials.
Against the trend, Andreas Halvorsen opened a new position in JD.com worth $658M.
- Andreas Halvorsen's largest Q2 2021 buy was JD.com: 8,241,079 shares worth $658M.
- Andreas Halvorsen added most to Amazon in Q2 2021, an estimated $974M increase.
- Andreas Halvorsen's biggest Q2 2021 reduction was Bank of America, cutting an estimated $989M.
- Andreas Halvorsen fully exited AbCellera Biologics in Q2 2021, selling an estimated $648M.
- Andreas Halvorsen's ten largest holdings make up 37% of its $33B portfolio in Q2 2021.
- Andreas Halvorsen opened 22 new positions and closed 29 in Q2 2021.
- Andreas Halvorsen's portfolio value fell 1.8% quarter-over-quarter to $33B.
Based on Viking Global Investors's 13F filing for Q2 2021, filed 16 Aug 2021.